Ngā hua rapu - D. Azria
- E whakaatu ana i te 1 - 20 hua o te 41
- Haere ki te Whārangi Whai Ake
-
1
-
2
New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstructi... mā P.L. Giacalone, Gauthier Rathat, Jean Pierre Daurès, P Bénos, D. Azria, Caroline Rouleau
I whakaputaina 2010Artigo -
3
-
4
-
5
Prophylactic Percutaneous Endoscopic Gastrostomy in Patients With Advanced Head and Neck Tumors Treated by Combined Chemoradiotherapy mā Eric Assénat, Simon Thézenas, Nicolas Flori, Nicole Pere-Charlier, R. Garrel, Antoine Serre, D. Azria, Pierre Sénesse
I whakaputaina 2011Artigo -
6
Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer mā S. Vieillot, D. Azria, C. Lemanski, C. Llacer Moscardo, Sophie Gourgou, Jean‐Bernard Dubois, N. Aillères, P. Fenoglietto
I whakaputaina 2010Artigo -
7
-
8
Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response mā Olivıer Turrini, Marc Ychou, Laurence Moureau-Zabotto, Philippe Rouanet, Marc Giovannini, Vincent Moutardier, D. Azria, Jean‐Robert Delpéro, F. Viret
I whakaputaina 2010Artigo -
9
Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans mā C. Menkarios, D. Azria, Benoit Laliberté, C. Llacer Moscardo, Sophie Gourgou, C. Lemanski, Jean‐Bernard Dubois, N. Aillères, P. Fenoglietto
I whakaputaina 2007Artigo -
10
-
11
In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptor... mā Christel Larbouret, Nadège Gaborit, Thierry Chardès, Mickaël Coelho, Emmanuelle Campigna, Caroline Mollévi, Jean‐Pierre Mach, D. Azria, Bruno Robert, André Pèlegrin
I whakaputaina 2012Artigo -
12
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy mā O. Lauche, Youlia Kirova, P. Fenoglietto, É. Costa, C. Lemanski, C. Bourgier, O. Riou, David Tiberi, François Campana, Alain Fourquet, D. Azria
I whakaputaina 2016Artigo -
13
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II s... mā Christophe Borg, Thierry André, G. Mantion, F. Boudghène, F. Mornex, P. Maingon, Antoine Adenis, D. Azria, M. Piutti, O. Morsli, Jean-François Bosset
I whakaputaina 2014Artigo -
14
Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN Trial mā Alain Tolédano, D. Azria, P. Garaud, Alain Fourquet, Daniel Serin, Jean-François Bosset, J. Miny-Buffet, A. Favre, O. Le Floch, G. Calais
I whakaputaina 2007Artigo -
15
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications mā D. Cowen, E. Groß, Philippe Rouannet, É. Teissier, Stephen B. Ellis, M. Resbeut, Agnès Tallet, V. Vaini Cowen, D. Azria, Jean‐Michel Hannoun‐Lévi
I whakaputaina 2010Artigo -
16
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients mā D. Azria, Sophie Gourgou, Wendy Jeanneret Sozzi, A. Zouhair, R.O. Mirimanoff, A. Kramar, C. Lemanski, Jean‐Bernard Dubois, Gilles Romieu, André Pèlegrin, Mahmut Özsahin
I whakaputaina 2004Artigo -
17
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study mā Yazid Belkacémi, Joseph Gligorov, Mahmut Özsahin, H. Marsiglia, B. De Lafontan, H. Laharie-Mineur, L. Aimard, Éric-Charles Antoine, B. Cutuli, M. Namer, D. Azria
I whakaputaina 2008Artigo -
18
<i>In vivo</i> Therapeutic Synergism of Anti–Epidermal Growth Factor Receptor and Anti-HER2 Monoclonal Antibodies against Pancreatic Carcinomas mā Christel Larbouret, Bruno Robert, Isabelle Navarro‐Teulon, Simon Thézenas, Maha Zohra Ladjemi, Sébastien Morisseau, Emmanuelle Campigna, Frédéric Bibeau, Jean‐Pierre Mach, André Pèlegrin, D. Azria
I whakaputaina 2007Artigo -
19
Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers mā Nadège Gaborit, Christel Larbouret, Julie Vallaghe, Frédéric Peyrusson, Caroline Mollévi, Evelyne Lopez‐Crapez, D. Azria, Thierry Chardès, Marie‐Alix Poul, Gérard Mathis, Hervé Bazin, André Pèlegrin
I whakaputaina 2011Artigo -
20
Intravoxel Incoherent Motion–derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Compari... mā Stéphanie Nougaret, Hebert Alberto Vargas, Yulia Lakhman, Romain Sudre, Richard Kinh Gian, Frédéric Bibeau, D. Azria, Eric Assénat, Nicolas Molinari, M.-A. Pierredon, Philippe Rouanet, Boris Guiu
I whakaputaina 2016Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cancer
Radiation therapy
Oncology
Breast cancer
Surgery
Biology
Cancer research
Pancreatic cancer
Radiology
Chemoradiotherapy
Chemotherapy
Colorectal cancer
Randomized controlled trial
Trastuzumab
Biochemistry
Gastroenterology
Genetics
Prospective cohort study
Prostate cancer
Toxicity
Urology
Cetuximab
Epidermal growth factor receptor
Gene
Nuclear medicine
Physics
Regimen
Adjuvant